Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BUSPAR | Bristol Myers Squibb | N-018731 DISCN | 1986-09-29 | 4 products, RLD |
BUSPAR | Bristol Myers Squibb | N-021190 DISCN | 2000-12-20 | 4 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
buspar | ANDA | 2016-05-25 |
buspirone | ANDA | 2010-03-29 |
buspirone hcl | ANDA | 2023-06-29 |
buspirone hcl | ANDA | 2024-12-19 |
buspirone hydrochloride | ANDA | 2025-01-08 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | Buspirone |
INN | buspirone |
Description | Buspirone is an azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position. It has a role as an anxiolytic drug, a sedative, a serotonergic agonist and an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor. It is an azaspiro compound, a member of pyrimidines, a N-arylpiperazine, a N-alkylpiperazine, a member of piperidones and an organic heteropolycyclic compound. It is a conjugate base of a buspirone(1+). |
Classification | Small molecule |
Drug class | anxiolytics (buspirone type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1 |
PDB | — |
CAS-ID | 36505-84-7 |
RxCUI | — |
ChEMBL ID | CHEMBL49 |
ChEBI ID | 3223 |
PubChem CID | 2477 |
DrugBank | DB00490 |
UNII ID | TK65WKS8HL (ChemIDplus, GSRS) |